معرفی
Dr. Amy Johnson is a Lecturer in Biomedical Science at the Swansea University School of Medicine, Faculty of Medicine, Health and Life Science. She is affiliated with the Biomedical Sciences department and holds a fellowship from the Institute of Biomedical Science. Her research and teaching emphasize Neuroscience, Cellular Pathology, and Epigenetics.
- BSc (Hons) in Biomedical Science (2006)
- PhD in Neuroimmune Modulation of the Circadian Clock (2011)
Dr. Johnson's research spans Neuroscience, focusing on neurodegeneration, neuroprotection, and neurogenesis, with applications in neuroimmunology and metabolic peptides. She has also contributed to Computational Biology and Epigenetics in cancer research. Her recent publications explore ghrelin's neuroprotective effects, calorie restriction in neurogenesis, and epigenetic inhibitors for ovarian cancer.
She holds a key role in promoting academia-industry collaborations after a decade in industry, including positions at Porvair Sciences and Chromatrap. Her teaching involves postgraduate programs in Biomedical Science, specializing in Cellular Pathology and Diagnostic Histopathology.
- Ghrelin's impact on neuroinflammation and Parkinson's models
- Epigenetic drug discovery in ovarian cancer
Dr. Johnson is a STEM ambassador, actively engaging in public science initiatives. She is available for postgraduate supervision and works at the Institute of Life Science 1, Singleton Campus.
